Breaking News Bar

Business News and Information

Gilead CEO expects remdesivir to effectively treat Covid strains found in U.K., South Africa

"I expect remdesivir with these variants will continue to make an impact on patients," Gilead Sciences CEO Daniel O'Day told CNBC.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear